We are pleased to announce that the funding of the Sonderforschungsbereich 877 (SFB877) 'Proteolysis as a Regulatory Event in Pathophysiology' has been extended until June 2022. The SFB877 has been founded at the Biochemical Institute in 2010 and comprises projects from the Biochemical Institute, Anatomical Institute, Immunological Institute, Institute of Experimental Medicine, the Department of Dermatology from the University of Kiel and projects from the University Medical Centre Hamburg Eppendorf and the University of Mainz. The SFB877 also features a Graduate School with stipends for Medical Graduate Students.